Sartorius | SRT3 - Des Atouts

Prix De L'Action
217.10
Variation Quotidienne
2.20 1.02%
Mensuellement
0.74%
Annuel
-3.12%
Q2 Prévisions
211.39




Des Atouts Changement Date
Akebia Therapeutics USD 376.56M 12.41M 2025-12
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
Avita Medical AUD 56.39M 1.74M 2025-12
Dianthus Therapeutics USD 530.92M 46.52M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Moderna USD 12.34B 203M 2025-12
Organon & Co USD 13.55B 52M 2025-09
Revvity USD 12.17B 29.46M 2025-12
Sartorius EUR 9.87B 154.9M 2026-03
Tectonic Therapeutic USD 261.04M 15.96M 2025-12
Viatris USD 37.19B 727.3M 2025-12
Xeris Pharmaceuticals USD 383.53M 13.34M 2025-12